HIMS 8-K — Smart Summary
98% reductionOn May 29, 2026, Hims & Hers Health, Inc. entered into Amendment No. 3 to its Revolving Credit and Guaranty Agreement (originally dated February 18, 2025) with JPMorgan Chase Bank, N.A. as administrative and collateral agent, primarily to facilitate the Company's acquisition of EUC Management Pty Ltd (d/b/a Eucalyptus).
Item 1.01 — Entry into a Material Definitive Agreement
Agreements
- Amendment No. 3 to Revolving Credit and Guaranty Agreement — Parties: Hims & Hers Health, Inc. (borrower), subsidiary borrowers, guarantors, lenders, issuing banks, and JPMorgan Chase Bank, N.A. (administrative agent and collateral agent); effective May 29, 2026; amends the Credit Agreement originally dated February 18, 2025 (as previously amended by Amendment No. 1 dated June 25, 2025 and Amendment No. 2 dated May 7, 2026); key changes include: (a) provisions to facilitate the acquisition of EUC Management Pty Ltd ACN 631 013 860 (d/b/a Eucalyptus) including a grace period for covenant and representation/warranty compliance; (b) joinder obligations for material foreign subsidiaries; (c) increased downstream investment capacity in non-loan party subsidiaries; (d) no material changes to interest provisions, fees, covenants, or events of default
Conditions
- Grace Period for Covenant Compliance — The Amendment provides a grace period for the Company to comply with covenants and representations and warranties under the Credit Agreement as a result of the Eucalyptus acquisition; specific timeline not disclosed in the filing
- Joinder Obligations — Material foreign subsidiaries are required to become party to the Credit Agreement following the Amendment; specific timeline not disclosed in the filing
§ MORE SUMMARIES
More HIMS Smart Summaries
Other filings for Hims & Hers Health, Inc. with a Smart Summary.
8-K$HIMSHims & Hers Health, Inc.Smart Summary
8-K Filing
Issues $402.5M convertible notes due 2032
8-K$HIMSHims & Hers Health, Inc.Smart Summary
8-K Filing
Prices $350M convertible notes for international expansion and Eucalyptus
8-K$HIMSHims & Hers Health, Inc.Smart Summary
8-K Filing
Q2 2026 earnings results
Never miss a HIMS filing
Get real-time email alerts when HIMS files with the SEC.